|
DaunoxomeDrug - Daunoxome The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE, LIPOSOMAL; INJECTION
Active Ingredient(s) -
Daunorubicin Citrate
Strength -
EQ 2MG BASE/ML
Applicant -
GILEAD
New Drug Application (NDA) Number -
050704
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 8, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Gilead Sciences Inc
Daunoxome
Rev-eyes 0.5% Solution/drops; Ophthalmic
Aczone 5% Gel; Topical Dapsone 100mg Tablet; Oral Dapsone 25mg Tablet; Oral Cubicin 250mg/vial Injectable; Iv (infusion) Cubicin 500mg/vial Injectable; Iv (infusion) Enablex Eq 15mg Base Tablet, Extended Release; Oral Enablex Eq 7.5mg Base Tablet, Extended Release; Oral Daunoxome Eq 2mg Base/ml Injectable, Liposomal; Injection Dantrium 20mg/vial Injectable; Injection NewDrugInformation |